VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KGKestrel Group, Ltd.
$9.52$74M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksKGQuarterly Financials

Kestrel Group, Ltd. (KG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kestrel Group, Ltd. (KG) quarterly income statement — complete revenue, gross profit & net income history

KG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23
Revenue10.19M10.21M20.3M546K14.05M-7.43M752K631K28.9M25.21M21.75M
Revenue Growth %-27.45%-----129.49%-96.54%----
Medical Costs & Claims2.25M4.55M12.12M-5.57M-7.62M000000
Medical Cost Ratio %22.12%44.54%59.73%-1019.6%-54.26%0%0%0%0%0%0%
Gross Profit7.94M5.66M8.18M6.11M21.67M-7.43M752K631K28.9M25.21M21.75M
Gross Margin %77.88%55.46%40.27%1119.6%154.26%100%100%100%100%100%100%
Gross Profit Growth %-63.37%-----129.49%-96.54%----
Operating Expenses14.88M22.1M12.23M-64.31M30.3M01.18M1.18M000
OpEx / Revenue %146.03%216.47%60.26%-11778.75%215.71%0%157.05%186.69%0%0%0%
Depreciation & Amortization9K-222K00-6.07M000000
Combined Ratio %168.15%261.01%119.99%-12798.35%161.45%0%157.05%186.69%0%0%0%
Operating Income-6.95M-16.44M-4.06M70.42M-8.63M-162.34M-429K-547K3.63M-11.52M-5.53M
Operating Margin %-68.15%-161.01%-19.99%12898.35%-61.45%2184.3%-57.05%-86.69%12.54%-45.72%-25.41%
Operating Income Growth %19.53%-----1308.81%92.24%----
EBITDA-6.94M-16.66M71K71.94M-14.7M-151.47M-429K-547K5.68M-16.42M-934K
EBITDA Margin %-68.07%-163.19%0.35%13176.56%-104.62%2038.13%-57.05%-86.69%19.65%-65.15%-4.29%
Interest Expense3.9M4.22M4.13M1.52M4.82M4.82M04.82M4.82M4.82M4.81M
Non-Operating Income-3.9M-4.22M-4.13M-1.52M-4.82M-10.86M00-2.05M4.9M-4.59M
Pretax Income-6.95M-16.44M-4.08M70.42M-8.63M-157.41M-429K-547K1.47M-20.33M-3.56M
Pretax Margin %-68.15%-161.01%-20.1%12898.35%-61.45%2118.03%-57.05%-86.69%5.09%-80.66%-16.35%
Income Tax6K-34K7K3K12K577K0011K449K-31K
Effective Tax Rate %-0.09%0.21%-0.17%0%-0.14%-0.37%0%0%0.75%-2.21%0.87%
Net Income-7.43M-17.75M-5.05M69.93M-8.64M-157.99M-429K-547K1.44M-20.78M-3.53M
Net Margin %-72.9%-173.93%-24.89%12807.14%-61.53%2125.79%-57.05%-86.69%4.99%-82.44%-16.21%
Net Income Growth %14.04%-----660.26%87.84%----
EPS (Diluted)-0.96-2.29-0.6515.05-1.74-31.83-6.91-0.060.29-4.12-0.70
EPS Growth %44.83%-----672.57%-887.14%----
EPS (Basic)-0.96-2.29-0.6515.05-1.74-31.83-6.91-0.060.29-4.12-0.70
Diluted Shares Outstanding7.75M7.74M7.74M4.64M4.96M4.96M4.99M9.94M5.02M5.04M5.07M